Literature DB >> 3052334

The epidemiology of shigellosis in Israel.

M Dan1, D Michaeli, J Treistman.   

Abstract

Analysis of Shigella isolates referred for serotyping to the Central Shigella Reference Laboratory has revealed a slight predominance of S. sonnei (47%) over S. flexneri (44%) in Israel. In female patients, the predominance of S. sonnei isolates was more accentuated (54 v. 37.5% for S. flexneri). On the other hand, an increased incidence of S. flexneri was observed in military personnel (59 v. 32% for S. sonnei), and even more so in the Arab population (69 v. 19%). Incidence peaked in summer (July, August) for all subgroups.

Entities:  

Mesh：

Year:  1988        PMID： 3052334     DOI： 10.1080/00034983.1988.11812223

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


  4 in total

1.  Marked decrease in susceptibility of Shigella to ampicillin and cotrimoxazole in Israel.

Authors:  M Dan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

2.  Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.

Authors:  J H Passwell; E Harlev; S Ashkenazi; C Chu; D Miron; R Ramon; N Farzan; J Shiloach; D A Bryla; F Majadly; R Roberson; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Epidemiology of Shigella infections in two ethnic groups in a geographic region in southern Israel.

Authors:  Y Finkelman; P Yagupsky; D Fraser; R Dagan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

4.  Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992.

Authors:  S Ashkenazi; M May-Zahav; J Sulkes; R Zilberberg; Z Samra
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.